baber/WOPTO huggingface dataset:
Patent AU-2001286539-B2 (AU)
Title: Apparatus and methods for the automated synthesis of oligosaccharides
Inventor: SEEBERGER PETER H
IPC: C07B61/00
Filed: 2001-08-17
Granted: 2007-01-04
Abstract: One aspect of the present invention relates to an apparatus for the efficient synthesis of oligosaccharides on a solid support, e.g., formed by subunit addition to terminal subunits immobilized on solid-phase particles. In certain embodiments, the apparatus of the present invention is used in combinatorial methods, e.g., as described herein, of synthesizing oligosaccharides.
Patent AU-2002238537-B2 (AU)
Title: Hybridoma cell line G250 and its use for producing monoclonal antibodies
Inventor: OOSTERWIJK EGBERT
IPC: A61K38/00
Filed: 2002-02-07
Granted: 2006-07-20
Abstract: The invention relates to novel nucleic acid sequences which encode an antibody suitable in the field of tumor diagnostics and therapeutics. Further, a method of producing recombinant antibodies is provided, wherein the novel nucleic acid sequencs are employed.
Patent AU-2002244020-B2 (AU)
Title: Methods of treating diabetes mellitus
Inventor: STILL JAMES GORDON
IPC: A61K38/00
Filed: 2002-02-14
Granted: 2007-08-16
Abstract: Methods of treating diabetes mellitus in a patient in need of such treatment include administering an effective amount of an insulin polypeptide-oligomer conjugate of formula V to the patient in order to treat diabetes mellitus in the patient. Methods according to the present invention may "activate" the liver, potentially restoring normal glucose homeostasis to individuals suffering from diabetes mellitus.
Patent AU-2002254099-B2 (AU)
Title: Cathepsin cysteine protease inhibitors
Inventor: BAYLY CHRISTOPHER IAN
IPC: C07D285/06
Filed: 2002-03-01
Granted: 2006-07-06
Abstract: This invention relates to a novel class of compounds which are cysteine protease inhibitors, including but not limited to, inhibitors of cathepsins K, L, S and B. These compounds are useful for treating diseases in which inhibition of bone resorption is indicated, such as osteoporosis.
Patent AU-2002317952-B2 (AU)
Title: Inductive position detector
Inventor: GLASGOW GEOFFREY
IPC: G01D5/249
Filed: 2002-07-03
Granted: 2005-04-28
Abstract: Inductive position detector ( 10 ) is described which includes scale ( 20 ) having a longitudinal axis containing a train of magnetic balls ( 22 ), and a transducer ( 30 ) moveable relative to the scale ( 20 ). The transducer ( 30 ) includes means to induce a magnetic field in the scale ( 20 ). Magnetic markers ( 23 ) are provided at axially spaced locations along the scale ( 20 ). As the transducer ( 30 ) is moved along the scale ( 20 ), the pattern of magnetic markers ( 23 ) detected enables the position of the transducer to be determined.
Patent AU-2002347036-B2 (AU)
Title: Method for producing aqueous styrene-butadiene polymer dispersions II
Inventor: MANDERS LAMBERTUS
IPC: C08F2/22
Filed: 2002-09-30
Granted: 2007-12-13
Abstract: A process for preparing an aqueous styrene-butadiene polymer dispersion by free-radical aqueous emulsion polymerization of a monomer mixture M containing from 40 to 80% by weight of styrene as monomer M1, from 20 to 60% by weight of butadiene as monomer M2, and from 0 to 40% by weight, based on 100% by weight of monomers, of ethylenically unsaturated comonomers M3 other than styrene and butadiene by a monomer feed technique in the presence of from 0.05 to 0.5% by weight, based on 100% by weight of monomers, of at least one hydrocarbon HC having 6 to 20 carbon atoms selected from compounds which on abstraction of a hydrogen atom form a pentadienyl radical or a 1-phenylallyl radical and alpha-methylstyrene dimer comprises raising, at a point in time when at least 70% of the monomers to be polymerized have been supplied to the polymerization reaction, the concentration of butadiene in the monomer feed for a period of at least 1% of the total feed time by at least 10% by weight, based on monomers in the feed.
Patent AU-2003209482-B2 (AU)
Title: Apparatus for dispersion compensating a signal that propagates along a signal path
Inventor: ZERVAS MIKHAIL NICKOLAOS
IPC: H04B10/2519
Filed: 2003-03-10
Granted: 2008-07-17
Abstract: Apparatus for dispersion compensating a signal ( 18 ) that propagates along a signal path ( 19 ), which apparatus comprises a grating ( 1 ) and a tuning means ( 2 ). The grating ( 1 ) is characterized by a wavelength operating range ( 3 ) and a group delay ( 4 ) that varies with wavelength ( 5 ), wherein the group delay ( 4 ) is equal at a plurality of pairs of wavelengths ( 6 ), ( 7 ) that are separated within the wavelength operating range ( 3 ), and wherein the grating ( 1 ) reflects each wavelength pair ( 6 ) from the same region ( 8 ) of the grating ( 1 ), and different wavelength pairs ( 7 ) from different regions ( 9 ) of the grating ( 1 ).
Patent AU-2003227949-B2 (AU)
Title: 5-HT4 receptor antagonists for the treatment of heart failure
Inventor: LEVY FINN OLAV
IPC: A61K31/5365
Filed: 2003-05-16
Granted: 2008-12-11
Abstract: This invention provides the use of a 5-HT4 receptor antagonist in the manufacture of a medicament for treating or preventing heart failure. Particular heart disorders to be treated are selected from the group comprising chronic heart failure, congestive heart failure, chronic congestive heart failure and heart failure resulting from ischaemic heart disease. Methods of treating heart failure using 5-HT4 receptor antagonists and pharmaceutical compositions containing 5-HT4 receptor antagonists are also provided.
Patent AU-2003253495-B2 (AU)
Title: System of bellows and co-acting part, pump and method for the use thereof
Inventor: NEERINCX PETER EDUARD
IPC: B05B11/00
Filed: 2003-07-03
Granted: 2007-05-17
Abstract: The present invention provides an assembly of bellows part and a part against which unrolling takes place (the unrolling part), comprising a bellows part with a flexible wall of a predetermined shape and thickness variation which co-operates with an unrolling part with a stiff outer wall along which the flexible wall is movable, wherein the unrolling part has a predetermined diameter variation and/or the flexible wall has a predetermined thickness variation so as to cause a desired development of force.
Patent AU-2003302895-B2 (AU)
Title: Connector for use with a medical catheter and medical catheter assembly including said connector
Inventor: HOLMES JOHN C
IPC: A61J15/00
Filed: 2003-12-09
Granted: 2009-04-23
Abstract: Connector for use with a medical catheter assembly and medical catheter assembly including the connector. In one embodiment, the connector comprises a rear portion, an intermediate portion, and a front portion. The rear portion is frusto-conical in shape and tapers rearwardly in cross-sectional diameter from its front end. A centrally-disposed, smaller-diameter, longitudinal bore is provided in the rear portion, the bore being appropriately dimensioned to receive a guidewire therethrough. The intermediate portion is generally cylindrical and is shaped to include a centrally-disposed, larger-diameter longitudinal bore and a pair of longitudinally-extending slots providing access to the larger-diameter bore. The front portion is frusto-conical in shape and tapers forwardly in cross-sectional diameter from its rear end. In use, a silicone tube is inserted into the larger-diameter bore of the intermediate portion, and the rear and intermediate portions of the connector are inserted into a gastrostomy feeding tube. A silicone glue is then used to bond the silicone tube to the gastrostomy feeding tube. The front end of the connector is inserted into a dilator and is secured thereto by spin-welding.
Patent AU-2004205142-B2 (AU)
Title: Directly engaged syringe driver system
Inventor: SHEARN JAMES G J
IPC: A61M5/145
Filed: 2004-08-19
Granted: 2007-11-22
Abstract: A syringe driver system comprises a rotatable threaded lead screw shaft and a plunger which directly engages the threaded shaft such that rotation of the shaft drives the plunger into the syringe body. The plunger is formed with a threaded shaft engaging portion in the form of a half nut to engage with and follow the threaded shaft. The syringe driver system further comprises a guide system to secure the plunger in direct engagement with the threaded shaft and to prevent rotation of the plunger. An arm of the plunger stem carries markers useful in determining the near end of infusion. The syringe body carries a marker or markers useful in determining a characteristic about the syringe, such as its volume. <IMAGE>
Patent AU-2004213855-B2 (AU)
Title: Methods and compositions for the treatment of cancer and infectious disease using alpha (2) macroglobulin-antigenic molecule complexes
Inventor: BINDER ROBERT J
IPC: A61K39/00
Filed: 2004-02-20
Granted: 2010-03-04
Abstract: The present invention relates to the use of alpha (2) macroglobulin complexes isolated from the serum of a mammal. The invention also relates to methods for making such complexes and compositions comprising alpha (2) macroglobulin complexes, isolated from the serum of a mammal, wherein such compositions are used in methods for the treatment and prevention of cancer and infectious disease. The invention also relates to methods for treating and preventing cancer and infectious disease using such complexes comprising, isolated from the serum of a mammal. The invention also encompasses methods for production of alpha (2) macroglobulin complexes.
Patent AU-2004263739-B2 (AU)
Title: An impact compactor
Inventor: STROMSOE ROGER ARNOLD
IPC: E02D3/026
Filed: 2004-08-06
Granted: 2009-11-19
Abstract: This invention relates to an impact compactor including a wheeled chassis structure and at least one non-round roller carried on an axle assembly. The axle assembly is rotatably mounted on a drag link, which is pivotally mounted on the chassis structure. The compactor includes also a lifting arrangement for lifting the roller from the ground, including a lifting arm, located above the drag link and pivotally displaceable with respect to the chassis structure, and a piston/cylinder mechanism for pivoting it. The lifting arm has a depending lifting formation that can releasably engage either one of the drag link and the axle assembly carried by the drag link for raising the roller from the ground. The configuration of the lifting arrangement provides for suitable accommodation of the piston/cylinder mechanism, which is problematic in some conventional-type compactors and associated with certain risks of mechanical failure during compaction operations.
Patent AU-2005244378-B2 (AU)
Title: Cleaning appliance
Inventor: WHITE WILLIAM ROBERT JAMES
IPC: A47L5/36
Filed: 2005-04-21
Granted: 2008-12-18
Abstract: A cleaning appliance has a main body and a hose attached thereto, the hose being attached to the main body by means of a connector. The connector is movable between a first position in which the hose is stored on the main body and a second position in which the hose provides a dirty airflow to the main body for cleaning purposes. When the connector is in the second position, the hose extends away from the main body in a plane which passes through the centre of the main body. This improves the balance of the main body during use.
Patent AU-2005270825-B2 (AU)
Title: Food products for diabetics
Inventor: AVIDOR SHULMAN
IPC: A23L33/20
Filed: 2005-08-09
Granted: 2011-07-07
Abstract: Disclosed is a novel food product characterized by a low glucose or glucose free content, a balanced functional fat content, and a proactive agent aimed for the diabetic and diabetic-prone populations. The food product of the invention is a functional food which may be used clinically to lower the lipid level in people suffering from an imbalanced lipid profile and which may progress towards diabetes complications and coronary vascular disorders. In particular embodiments the proactive agent can be any of a naturally occurring lipid, a synthetic or mimetic lipid which is not digestible by humans and interferes with body weight gain/loss, plant extracts and substances derived therefrom, antioxidants, animal-derived substances, minerals and pharmaceuticals, and any mixture thereof.
Patent AU-2005286092-B2 (AU)
Title: Temporary dental prosthesis
Inventor: MORDEHAI LAST-POLLAK
IPC: A61C13/107
Filed: 2005-09-15
Granted: 2011-10-20
Abstract: A temporary prosthesis for use during the osseointegration process of an installed dental implant comprises load-absorbing properties and is mountable to the implant, providing an aesthetic appearance to the implant site, while preventing or minimizing loads on the implant itself.
Patent AU-2005299369-B2 (AU)
Title: Yarns containing filaments made from shape memory alloys
Inventor: JONATHAN MARTINEK
IPC: A61L17/06
Filed: 2005-10-25
Granted: 2012-01-12
Abstract: Braids and surgical devices are made from yarns that include at least one filament made from a shape memory material.
Patent AU-2005316454-B2 (AU)
Title: Processes for producing 4-aminoquinazolines
Inventor: SILVA RICHARD A
IPC: C07D265/24
Filed: 2005-12-15
Granted: 2012-09-06
Abstract: The present invention relates to methods for preparing compounds of formula (I): or suitable salts thereof useful as inhibitors of voltage-gated sodium channels and calcium channels. The invention also relates to methods for preparing intermediates related thereto.
Patent AU-2005337383-B2 (AU)
Title: A method for the use in a battery alarm of a hearing aid, a circuit for monitoring an electric cell, and a hearing aid with such circuit
Inventor: TOFT OLE ERIK
IPC: H04R25/00
Filed: 2005-10-14
Granted: 2009-07-16
Abstract: A method for monitoring the supply voltage of a hearing aid comprising an electric cell (1) comprises the steps of counting the number of times the supply voltage falls below a predetermined value, and setting an alarm flag if said number of times reaches a predetermined value. The method may be implemented using a circuit for monitoring the supply voltage of an electric cell. The circuit comprises a timer timing a detection interval, a detector for detecting drops in the voltage below a predetermined threshold value, a counter for counting the number of detections within said detecting interval, means (3) for setting an alarm flag if said number of times reaches a predetermined value within said first detection interval, and means (12) for suspending alarms during warm-up phase.
Patent AU-2006202243-B2 (AU)
Title: Methods and compositions relating to modulation of hepatocyte growth, plasma cell differentiation of T cell subset activity by modulation
Inventor: REIMOLD ANDREAS M
IPC: G01N33/74
Filed: 2006-05-26
Granted: 2010-06-03
Abstract: The invention demonstrates that the transcription factor XBP-1 is a regulator of hepatocyte growth, plasma cell differentiation and T cell subset activity. Methods for identifying modulators of hepatocyte growth, plasma cell differentiation and/or T cell subset activity, using XBP-1-containing indicator compositions or XBP-1-deficient cells, are provided. Methods of modulating hepatocyte growth, plasma cell differentiation and/or T cell subset activity (e.g., Th2 cytokine production) using agents that modulate the activity of XBP-1 are also provided. Methods for diagnosing disorders associated with aberrant hepatocyte growth, plasma cell differentiation and/or T cell subset activity, by assessing a change in XBP-1 expression, are also provided. XBP-1 deficient cells, animals and embryos, as well as kits for the methods of the invention, are also provided by the invention.
Patent AU-2006233219-B2 (AU)
Title: Targets and methods for ultrasound catheter calibration
Inventor: CLAUDIO ALTMANN ANDRES
IPC: A61B8/00
Filed: 2006-10-27
Granted: 2011-11-03
Abstract: A method for calibrating an ultrasound probe includes directing the probe to receive ultrasonic waves reflected from a target that includes one or more linear 5 elements, which are arranged to intersect the beam plane of the probe at respective intersection points. Signals are received from the probe responsively to the reflected ultrasonic waves, and the probe is aligned by modifying at least one of a position and an orientation of the probe responsively to the signals so that the intersection points occur in a desired location in the beam plane. ['N1 Nc Nl Nc cvco C',z C~Co
Patent AU-2006278150-B2 (AU)
Title: Inhibitors of cancer cell, T-cell and keratinocyte proliferation
Inventor: KRALIK MARTIN
IPC: A61K38/04
Filed: 2006-08-10
Granted: 2012-03-08
Abstract: The invention relates to compounds of the general formula (I) and salts and physiologically functional derivatives thereof, wherein Y is -NRR, -NRC=ONRR -NRC=SNRR, -NRC=NRNR, heterocycle, - C=ONRR, heterocycle, or aryl; n is O to 8; m is 0, or 1 ; r is 0 to 3; t is O to 3; X is O or N; Z is CH, C=O, C=S or a single bond; Z is CO-R, CS-R, (CH)-R or the side-chain of a naturally occuring amino acid; , Z is CO-R , CS-R or (CH)-R or the side-chain of a naturally occuring amino acid; Z is CO-R, CS-R or (CH)-R or the side-chain of a naturally occuring amino acid; Zis H, alkyl, alkoxy, or cycloalkyl; R, R, R, and R are independently from each other H, OH, SH, NH, CN, NO, alkyl, cycloalkyl, heterocycloalkyl, haloalkyl, alkylthio, haloalkyloxy, hydroxyalkyl, hydroxyalkylarnino, alkylamino, alkylaryl, alkylsulfinyl, alkylsulfonyl, alkylthioalkyl, alkylsulfinylalkyl, alkylsulfonylalkyl, alkoxyalkyl, alkoxy, aryloxy, heteroaryl, aryl, or halogen.
Patent AU-2006278397-B2 (AU)
Title: Oxazolopyridine derivatives as sirtuin modulators
Inventor: BEMIS JEAN
IPC: A61P21/00
Filed: 2006-08-04
Granted: 2013-01-17
Abstract: Provided herein are oxazolopyridine derivatives which are sirtuin-modulating compounds and methods of use thereof. The sirtuin-modulating compounds may be used for increasingthe lifespan of a cell, and treating and/or preventing a wide variety of diseases and disorders including, for example, diseases or disorders related to aging or stress, diabetes, obesity, neurodegenerative diseases, cardiovascular disease, blood clotting disorders, inflammation, cancer, and/or flushing as well as diseases or disorders that would benfêt from increased mitochondrial activity. Also provided are compositions comprising a sirtuin-modulating compound in combination with another therapeutic agent.
Patent AU-2006305271-B2 (AU)
Title: Fused heterocyclic derivative, medicinal composition containing the same, and medicinal use thereof
Inventor: KOHSUKE OHNO
IPC: A61P17/14
Filed: 2006-10-17
Granted: 2011-11-17
Abstract: A compound useful as a preventive or therapeutic agent for sexual-hormone-dependent diseases, etc. It is a fused heterocyclic derivative represented by the following general formula (I). In the formula (I), ring A is a five-membered cyclic unsaturated hydrocarbon or five-membered heteroaryl; R is halogeno, alkyl, alkenyl, alkynyl, carboxy, alkoxy, carbamoyl, alkylcarbamoyl, etc.; ring B is aryl or heteroaryl; R is halogeno, alkyl, carboxy, alkoxy, carbamoyl, alkylcarbamoyl, etc.; E and E each is oxygen, etc.; U is a single bond or alkylene; and X is, e.g., a group represented by Y, -SO-Y, -O-(alkylene)-Y-, or -O-Z (wherein Y is Z, amino, etc. and Z is cycloalkyl, heterocycloalkyl, aryl, heteroaryl, etc.).
Patent AU-2006306487-B2 (AU)
Title: Heat exchanger assembly for a charge air cooler
Inventor: DIERBECK ROBERT F
IPC: F28D1/02
Filed: 2006-10-20
Granted: 2010-05-27
Abstract: A heat exchanger assembly for an internal combustion engine charge air cooler is formed from a plurality of aluminum modules, each provided with longitudinal through bores and opposite outer face portions with toothed heat exchange fins positioned in face-to-face relation. The assembly of tubular modules is interconnected with upper and lower aluminum header plates which receive the ends of the tubular modules and are secured thereto with fused joints made from the parent material of the modules and header plates. The openings in the header plates for the modules are flanged and have a thickness of at least about 0.090 inch and the wall thickness of the ends of the tubular modules also have a minimum thickness of about 0.90 inch such that the fused joints utilize substantially equal amounts of aluminum material from the modules and the header plate flanges.
Patent AU-2006315458-B2 (AU)
Title: Bulk resin infusion system apparatus and method
Inventor: HANKS DENNIS J
IPC: B29C33/00
Filed: 2006-11-14
Granted: 2011-06-02
Abstract: A composite item is fabricated in system that includes a layer of preform, supply of resin, mandrel, and bagging film. The layer of preform corresponds to the composite item. The supply of resin is sufficient to infuse the preform. The mandrel includes a preform receiving zone to receive the layer of preform and a resin receiving zone to receive the supply of resin. The resin receiving zone is adjacent to the preform receiving zone. The bagging film is operable to generate an envelope surrounding the preform receiving zone and the resin receiving zone.
Patent AU-2007250624-B2 (AU)
Title: A method to reduce the symptoms of heartburn and gastro-oesophageal reflux disease (GERD) by specific polysaccharides
Inventor: VERBRUGGEN MARIA ANNA
IPC: A61K9/00
Filed: 2007-05-16
Granted: 2012-09-20
Abstract: The invention is directed to the use of a specific group of polysaccharides for reducing the symptoms of heartburn and gastroesophageal reflux isease. In addition, a pharmaceutical preparation is provided comprising a specific group of polysaccharides having a high hydration rate, a high viscosity, and a high stability at low pH. Such a preparation is particularly effective in reducing the symptoms of heartburn and/or gastro-oesophageal reflux disease, particularly when consumed in dry form.
Patent AU-2007281416-B2 (AU)
Title: Compositions and methods of reducing tissue levels of drugs when given as orotate derivatives
Inventor: KARMALI RASHIDA A
IPC: A61K31/167
Filed: 2007-08-06
Granted: 2013-10-17
Abstract: This invention is in the field of chemical restructuring of pharmaceutical agents known to cause tissue toxicity as a side effect, by producing their orotate derivatives. More particularly, it concerns orotate derivatives of the anthracyclines, doxorubicin and daunorubicin, that are found to reduce levels of the pharmaceutical agent in noncancerous tissues. There orotate derivatives are equally efficacious in inhibiting the SCCAKI-I kidney tumor in animals and the reduction in the heart tissue of doxorubicin compared with doxorubicin HC1 suggests a reduction in toxicity induced by free radical generation by the anthracyclines.
Patent AU-2007292388-B2 (AU)
Title: Adhesively mountable angled wall shelf
Inventor: NEWBOULD PETER J
IPC: A47B67/00
Filed: 2007-09-04
Granted: 2011-01-20
Abstract: A wall mountable shelf for storing items in a shower or bath enclosure includes a frame, a base member connected with the frame, a back plate connected with the frame and arranged to support the frame on the wall, and adhesive arranged between the back plate and the wall for securing the shelf to the wall surface. The frame includes a top rail portion, a front rail portion, and a pair of side rail portions connecting the top rail portion and the front rail portion. Each side rail portion includes a back portion extending downwardly from the top rail portion and a bottom portion extending from the back portion to the front rail portion arranged at an angle of less than 90°.
Patent AU-2007301920-B2 (AU)
Title: Method for coating a cooling element
Inventor: YRJO LEPPANEN
IPC: C21B7/10
Filed: 2007-09-07
Granted: 2011-07-14
Abstract: The invention relates to a method for coating a cooling element (1) mainly made of copper, provided with water cooling pipes (2) and used particularly in connection with metallurgic furnaces or the like, wherein the cooling element includes a fire surface (3) that is in contact with molten metal, suspension or process gas; side surfaces (6) and an outer surface (7), so that at least part of the fire surface (3) is coated by a corrosion resistant coating (5).